JP2006514934A - 疼痛治療用薬剤製造のためのロキサピンまたはアモキサピンの使用 - Google Patents
疼痛治療用薬剤製造のためのロキサピンまたはアモキサピンの使用 Download PDFInfo
- Publication number
- JP2006514934A JP2006514934A JP2004555617A JP2004555617A JP2006514934A JP 2006514934 A JP2006514934 A JP 2006514934A JP 2004555617 A JP2004555617 A JP 2004555617A JP 2004555617 A JP2004555617 A JP 2004555617A JP 2006514934 A JP2006514934 A JP 2006514934A
- Authority
- JP
- Japan
- Prior art keywords
- loxapine
- pain
- administration
- compound
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Description
実施例1
マウスのもがき(ライジング)行動試験
[0050] 体重23〜28gの雄マウスをこの試験に用いた。マウスに酢酸を注射した(0.5%、腹腔内)。この処置により、対照動物に認識可能なもがき反応が誘発される。酢酸注射の5分後から10分間のもがきの回数をカウントする。1グループ当たり10匹のマウスを試験した。試験は盲検で行った。酢酸の30分前に腹腔内投与した、5つの投与量でのロキサピンおよびアモキサピン(0.2%ヒドロキシプロピルメチルセルロース中に分散し、次いで食塩水に溶解した)について評価し、これを溶媒対照(0.2%ヒドロキシプロピルメチルセルロースの食塩水溶液)グループと比較した。ロキサピンの投与量は、体重1kg当たり0.125、0.25、0.5、1および2mgであった。アモキサピンの投与量は、体重1kg当たり1、2、4、8および16mgであった。モルヒネ(8mg/kg、腹腔内)を同じ実験条件下で投与し、これを基準物質として用いた。マンホイットニーU検定を使用して、処置グループを溶媒対照と比較することによってデータを解析した。
ビーグル犬におけるロキサピンの吸入型エアロゾル製剤の急性および5日反復投与毒性試験
[0053] この試験の目的は、イヌに5日間反復投与する試験で、個々の最大忍容量、および2つの臨床的に重要な投与量でのロキサピンの潜在的な毒性を調べることであった。
実施例3
ロキサピン濃縮エアロゾル剤の第I相臨床試験
[0084] 2003年8月4日出願の「Rapid−Heating Drug Delivery Article and Method of Use」という名称の米国特許出願10/633,876に開示されている手持ち型濃縮エアロゾル発生装置を、患者の吸入によって装置が作動してから1秒未満の間にロキサピン濃縮エアロゾルを(被覆の厚さに応じて)0、2.5mg、5mgまたは10mgを放出するようにロキサピンで被覆する。
急性偏頭痛発作の治療に関するロキサピンの第II相臨床試験
[0089] この試験の方法は、二重盲検無作為化プラセボ対照投与量範囲設定試験である。18〜65歳の、その両端の年齢を含めた健常な男女であり、自己報告による中程度から重度の偏頭痛(前兆を伴うまたは伴わない偏頭痛)歴があり、過去3カ月の間に1カ月当たり1〜6回の平均頻度で発作を起こした被験者を募集して、試験に参加させる。参加基準を満たしている被験者を登録し、無作為化して以下の治療のうち1つを受けさせる。プラセボ投与、ロキサピン急速送達システムで約1.25mg投与、ロキサピン急速送達システムで約2.5mg投与、ロキサピン急速送達システムで約5mg投与、ロキサピン急速送達システムで約10mg投与。これより高い投与量のロキサピンはまた、第I相臨床試験で安全であると認められた場合に試験することもできる。ロキサピン急速送達システムとは、最大血漿薬剤濃度が1時間、30分、15分、10分、5分、さらに2分以下の時間内にでも得られるように、ロキサピンを偏頭痛患者に送達する手段である。第I相臨床試験に関して上記の濃縮エアロゾル送達システムは、そのようなシステムの1つである。他の急速送達システムには、様々な持続時間の静脈内注入または注射が含まれる。
急性偏頭痛発作の治療に関するロキサピンの臨床使用
[0092] 通常は良好な健康状態の35歳の女性が、家にいる間に頭の右側に局在する中程度の疼痛が生じ約10分間続いたことに気づく。その次の10分間に、その疼痛は、よりひどくなり、ズキズキすることを特徴とするものになる。その女性は、これを偏頭痛であると認識し、このような頭痛では、治療しないと、少なくともそれが丸一日持続する傾向があり、頭痛に伴い悪心が生じ、その疼痛が非常にひどいので眠ることが困難または不可能になることも分かる。その女性は、眼に入る明るい光によって生じる疼痛を避けるために居間の照明を消し、ラジオの音で頭痛がひどくなっているのでラジオを消す。彼女は、25mgロキサピン錠剤を口から1杯の水で飲む。その次の15分間に、頭痛はひどくなり始め、その女性の胃の調子が少し悪くなる。しかし、その次の1時間に、頭痛はゆっくりと軽くなり、その女性はだんだんと疲れてくる。胃の調子はもはや気にならなくなる。彼女は少しうたた寝をし、頭痛の何の徴候もない状態で目覚める。光および音は、もはや煩わしいものではない。彼女は、胃の調子が悪いこともなく通常の食事をとる。頭痛は、その次の72時間に再び生じることはなく、さらなる薬剤の服用は不要である。
Claims (24)
- 対象の疼痛を治療する方法であって、ロキサピン、薬学的に許容されるロキサピンの塩およびロキサピンのプロドラッグからなる群から選択される化合物の有効量を、前記対象に投与することを含む方法。
- 前記有効量が、前記対象に存在する疼痛を軽減するのに十分な量である、請求項1に記載の方法。
- 前記化合物が全身投与される、請求項1に記載の方法。
- 前記疼痛が、偏頭痛、群発性頭痛および緊張型頭痛からなる群から選択される、請求項1に記載の方法。
- 前記疼痛が偏頭痛である、請求項4に記載の方法。
- 前記疼痛が群発性頭痛である、請求項4に記載の方法。
- 前記疼痛が緊張型頭痛である、請求項4に記載の方法。
- 前記化合物が吸入によって投与される、請求項1に記載の方法。
- 前記対象がヒトであり、前記疼痛が偏頭痛であり、前記化合物が吸入によって投与される、請求項1に記載の方法。
- ロキサピンを約0.3〜約20mg投与する、あるいはロキサピンを約0.3〜約20mg投与するのと同じロキサピン血中濃度が対象に生じる量の、ロキサピンの塩またはプロドラッグを投与する、請求項1に記載の方法。
- ロキサピンを約1〜約10mg投与する、あるいはロキサピンを約1〜約10mg投与するのと同じロキサピン血中濃度が対象に生じる量のロキサピンの塩またはプロドラッグを投与する、請求項1に記載の方法。
- ロキサピンあるいはその塩またはプロドラッグの対象への投与が、前記投与から約30分以内にロキサピンの最大血中濃度となるように実施される、請求項10に記載の方法。
- ロキサピンあるいはその塩またはプロドラッグの対象への投与が、前記投与から約15分以内にロキサピンの最大血中濃度となるように実施される、請求項10に記載の方法。
- ロキサピンあるいはその塩またはプロドラッグの対象への投与が、ロキサピンの血中濃度のピーク増加速度が少なくとも約1ng/ml/分となるように実施される、請求項10に記載の方法。
- ロキサピンあるいはその塩またはプロドラッグの対象への投与が、前記投与から約15分以内にロキサピンの血中濃度が少なくとも約5ng/mlとなるように実施される、請求項10に記載の方法。
- 前記化合物が、急速加熱薬剤送達物品または薄膜薬剤送達物品を用いた吸入によって投与される、請求項1に記載の方法。
- エアロゾル中で少なくとも50%の前記化合物の回収率をもたらし、前記エアロゾルに含まれる化合物の分解産物が約5重量%未満であるように、気化され濃縮される前記化合物が、吸入送達装置によって投与される、請求項1に記載の方法。
- 膜の厚さが約0.5〜20μmである薄膜として、送達装置中の基体上に前記化合物が被覆されている、請求項17に記載の方法。
- 前記化合物が、空気動力学的中央粒径(MMAD)が約0.01〜約3μmであるエアロゾル剤の形で投与される、請求項1に記載の方法。
- 前記化合物の回収率が少なくとも50%であり、含まれる化合物の分解産物が約10重量%未満であるエアロゾル剤をもたらすのに十分な条件下で、化合物組成物膜から気化される前記化合物が、急速加熱薬剤送達物品によって投与される、請求項1に記載の方法。
- 疼痛を治療するための組成物であって、前記組成物が、(a)ロキサピン、薬学的に許容されるその塩、およびそのプロドラッグからなる群から選択される、鎮痛性を示す量の化合物と、(b)薬学的に許容される担体とを含む、組成物。
- 1種以上の鎮痛剤、抗炎症剤または抗偏頭痛剤をさらに含む、請求項21に記載の組成物。
- 疼痛を治療するための薄膜組成物であって、ロキサピン、薬学的に許容されるその塩、およびそのプロドラッグからなる群から選択される、鎮痛性を示す量の化合物を含み、膜の厚さが約0.5〜約20μmである、薄膜組成物。
- 対象の頭痛を治療する方法であって、ロキサピン、薬学的に許容されるロキサピンの塩およびロキサピンのプロドラッグからなる群から選択される化合物を、前記対象に有効量投与することを含む方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42940502P | 2002-11-26 | 2002-11-26 | |
PCT/US2003/037415 WO2004047844A1 (en) | 2002-11-26 | 2003-11-20 | Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2006514934A true JP2006514934A (ja) | 2006-05-18 |
Family
ID=32393557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004555617A Ceased JP2006514934A (ja) | 2002-11-26 | 2003-11-20 | 疼痛治療用薬剤製造のためのロキサピンまたはアモキサピンの使用 |
Country Status (15)
Country | Link |
---|---|
US (1) | US8288372B2 (ja) |
EP (1) | EP1567164B1 (ja) |
JP (1) | JP2006514934A (ja) |
CN (2) | CN1717237A (ja) |
AT (1) | ATE420647T1 (ja) |
AU (1) | AU2003294470B2 (ja) |
CA (1) | CA2507159A1 (ja) |
DE (1) | DE60325888D1 (ja) |
DK (1) | DK1567164T3 (ja) |
ES (1) | ES2321292T3 (ja) |
HK (1) | HK1125845A1 (ja) |
MX (1) | MXPA05005611A (ja) |
NZ (1) | NZ540207A (ja) |
PT (1) | PT1567164E (ja) |
WO (1) | WO2004047844A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015520154A (ja) * | 2012-05-18 | 2015-07-16 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | (1r,4r)−6’−フルオロ−N,N−ジメチル−4−フェニル−4’,9’−ジヒドロ−3’H−スピロ[シクロヘキサン−1,1’−ピラノ[3,4,b]インドール]−4−アミンおよび抗うつ薬を含む医薬組成物 |
US9629825B2 (en) | 2012-05-18 | 2017-04-25 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1392258B1 (en) * | 2001-05-24 | 2008-11-26 | Alexza Pharmaceuticals, Inc. | Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
JP2005503425A (ja) * | 2001-05-24 | 2005-02-03 | アレックザ モレキュラー デリヴァリー コーポレイション | 所定の吸入ルートによる薬剤エステルの送出 |
US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
US7645442B2 (en) | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
US20030051728A1 (en) | 2001-06-05 | 2003-03-20 | Lloyd Peter M. | Method and device for delivering a physiologically active compound |
AU2002363947A1 (en) * | 2001-11-21 | 2003-07-24 | Alexza Molecular Delivery Corporation | Delivery of caffeine through an inhalation route |
WO2003094900A1 (en) * | 2002-05-13 | 2003-11-20 | Alexza Molecular Delivery Corporation | Delivery of drug amines through an inhalation route |
US20060193788A1 (en) * | 2002-11-26 | 2006-08-31 | Hale Ron L | Acute treatment of headache with phenothiazine antipsychotics |
US7550133B2 (en) * | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
US20040105818A1 (en) | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
JP2006514633A (ja) * | 2002-11-26 | 2006-05-11 | アレックザ ファーマシューティカルズ, インコーポレイテッド | 吸入によって送達される抗精神病薬を用いた頭痛の治療 |
US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
WO2004104490A1 (en) | 2003-05-21 | 2004-12-02 | Alexza Pharmaceuticals, Inc. | Self-contained heating unit and drug-supply unit employing same |
US20050034723A1 (en) * | 2003-08-04 | 2005-02-17 | Bryson Bennett | Substrates for drug delivery device and methods of preparing and use |
MXPA06002279A (es) * | 2003-09-04 | 2006-05-17 | Lundbeck & Co As H | Combinacion de un inhibidor de la reabsorcion de serotonina y amoxapina. |
US7402777B2 (en) * | 2004-05-20 | 2008-07-22 | Alexza Pharmaceuticals, Inc. | Stable initiator compositions and igniters |
US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
RU2007137121A (ru) * | 2005-03-09 | 2009-04-20 | Оно Фармасьютикал Ко., Лтд. (Jp) | Частица и препарат, содержащий указанную частицу |
US20070087056A1 (en) * | 2005-08-09 | 2007-04-19 | Claudia Guthmann | Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility |
US20070259829A1 (en) * | 2006-03-24 | 2007-11-08 | Maen Abdelrahim | Uses of diphenyl/diphenylamine carboxylic acids |
WO2008080170A1 (en) * | 2006-12-22 | 2008-07-03 | Alexza Pharmaceuticals, Inc. | Mixed drug aerosol compositiions |
EP2121088B1 (en) | 2007-03-09 | 2016-07-13 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
EP2230934B8 (en) | 2007-12-14 | 2012-10-24 | AeroDesigns, Inc | Delivering aerosolizable food products |
US20100065052A1 (en) * | 2008-09-16 | 2010-03-18 | Alexza Pharmaceuticals, Inc. | Heating Units |
US7834295B2 (en) | 2008-09-16 | 2010-11-16 | Alexza Pharmaceuticals, Inc. | Printable igniters |
US20100300433A1 (en) * | 2009-05-28 | 2010-12-02 | Alexza Pharmaceuticals, Inc. | Substrates for Enhancing Purity or Yield of Compounds Forming a Condensation Aerosol |
US20120048963A1 (en) | 2010-08-26 | 2012-03-01 | Alexza Pharmaceuticals, Inc. | Heat Units Using a Solid Fuel Capable of Undergoing an Exothermic Metal Oxidation-Reduction Reaction Propagated without an Igniter |
US9345689B2 (en) | 2012-05-18 | 2016-05-24 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N, N-dimethyl-4-phenyl-4,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and an anticonvulsant |
CN105530916B (zh) | 2013-07-11 | 2020-04-07 | 艾利斯达医药品公司 | 与间水杨酸形成的烟碱盐 |
DK3268072T3 (da) | 2015-03-11 | 2024-01-22 | Alexza Pharmaceuticals Inc | Anvendelse af antistatiske materialer i luftvejen til termisk aerosolkondensationsproces |
US20170216220A1 (en) * | 2016-02-03 | 2017-08-03 | Intelgenx Corp. | Loxapine film oral dosage form |
WO2018107045A1 (en) | 2016-12-09 | 2018-06-14 | Alexza Pharmaceuticals, Inc. | Method of treating epilepsy |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3546226A (en) * | 1963-03-01 | 1970-12-08 | A Wander Sa Dr | 11-basic-substituted dibenzoxazepines |
JP2001518097A (ja) * | 1997-03-24 | 2001-10-09 | アドロール コーポレーション | 片頭痛の治療方法 |
WO2002000482A1 (en) * | 2000-06-23 | 2002-01-03 | R Rapich Limited | Trailer brake |
JP2002515503A (ja) * | 1998-05-18 | 2002-05-28 | ノボ ノルディスク アクティーゼルスカブ | オピオイド受容体のサブタイプへの高い親和性を有する新規1,3,8−トリアザスピロ〔4,5〕デカノン |
WO2002060870A2 (en) * | 2000-11-17 | 2002-08-08 | Adolor Corporation | Delta agonist analgesics |
WO2002098496A1 (en) * | 2001-06-05 | 2002-12-12 | Alexza Molecular Delivery Corporation | An aerosol forming device for use in inhalation therapy |
Family Cites Families (151)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB502761A (en) | 1938-01-29 | 1939-03-24 | Christopher Engelbreth | Improvements in and relating to hand inhalation apparatus |
US2902484A (en) | 1954-04-27 | 1959-09-01 | Rhone Poulenc Sa | Phenthiazine derivatives and processes for their preparation |
BE629985A (ja) | 1962-11-29 | |||
GB1063512A (en) | 1962-11-30 | 1967-03-30 | Benger Lab Ltd | Aerosols |
AT252925B (de) * | 1964-05-27 | 1967-03-10 | Wander Ag Dr A | Verfahren zur Herstellung neuer 11-basisch substituierter Dibenz[b,f][1,4]oxazepine |
USRE30285E (en) | 1972-05-22 | 1980-05-27 | Spraying devices, in particular nebulizing devices | |
US3949743A (en) | 1973-03-19 | 1976-04-13 | Schick Incorporated | Medicated vapor production method and apparatus |
US3982095A (en) | 1973-10-04 | 1976-09-21 | Searle Cardio-Pulmonary Systems Inc. | Respiratory humidifier |
US4141369A (en) | 1977-01-24 | 1979-02-27 | Burruss Robert P | Noncombustion system for the utilization of tobacco and other smoking materials |
US4183912A (en) | 1978-01-16 | 1980-01-15 | American Home Products Corporation | Inhalation therapy for relieving bronchial spasm using quaternary salts of promethazine |
US4303083A (en) | 1980-10-10 | 1981-12-01 | Burruss Jr Robert P | Device for evaporation and inhalation of volatile compounds and medications |
DE3116951C2 (de) | 1981-04-29 | 1984-12-20 | Drägerwerk AG, 2400 Lübeck | Vorrichtung zur Beimischung flüssiger Narkosemittel in das dem Patienten zuzuführende Atemgas |
DE3224849A1 (de) | 1982-07-02 | 1984-01-05 | Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn | Dampfinhaliergeraet |
US4474191A (en) | 1982-09-30 | 1984-10-02 | Steiner Pierre G | Tar-free smoking devices |
IT1173445B (it) | 1984-03-16 | 1987-06-24 | Guidotti & C Spa Labor | Agenti ad attivita' antibroncospastica e composizioni farmaceutiche che li contengono |
US5042509A (en) | 1984-09-14 | 1991-08-27 | R. J. Reynolds Tobacco Company | Method for making aerosol generating cartridge |
JPS63500175A (ja) | 1985-05-22 | 1988-01-21 | リポソ−ム テクノロジ−,インコ−ポレイテツド | リポソ−ム吸入法および吸入システム |
US4708151A (en) | 1986-03-14 | 1987-11-24 | R. J. Reynolds Tobacco Company | Pipe with replaceable cartridge |
US4735217A (en) | 1986-08-21 | 1988-04-05 | The Procter & Gamble Company | Dosing device to provide vaporized medicament to the lungs as a fine aerosol |
US4734560A (en) | 1987-01-20 | 1988-03-29 | Medical Enterprises, Ltd. | Vaporizing unit |
US4819665A (en) | 1987-01-23 | 1989-04-11 | R. J. Reynolds Tobacco Company | Aerosol delivery article |
US4924883A (en) | 1987-03-06 | 1990-05-15 | R. J. Reynolds Tobacco Company | Smoking article |
GB8713645D0 (en) | 1987-06-11 | 1987-07-15 | Imp Tobacco Ltd | Smoking device |
US4906417A (en) | 1988-02-08 | 1990-03-06 | Associated Mills Inc. | Humidifier |
US4853517A (en) | 1988-03-28 | 1989-08-01 | John G. Bowen | Vaporizing unit |
US5345951A (en) | 1988-07-22 | 1994-09-13 | Philip Morris Incorporated | Smoking article |
EP0358114A3 (en) | 1988-09-08 | 1990-11-14 | R.J. Reynolds Tobacco Company | Aerosol delivery articles utilizing electrical energy |
US4963289A (en) | 1988-09-19 | 1990-10-16 | The United States Of America As Represented By The United States Department Of Energy | Method for producing monodisperse aerosols |
US5511726A (en) | 1988-09-23 | 1996-04-30 | Battelle Memorial Institute | Nebulizer device |
US4917119A (en) | 1988-11-30 | 1990-04-17 | R. J. Reynolds Tobacco Company | Drug delivery article |
US4906476A (en) | 1988-12-14 | 1990-03-06 | Liposome Technology, Inc. | Novel liposome composition for sustained release of steroidal drugs in lungs |
DE3908161A1 (de) | 1989-03-13 | 1990-09-27 | Bat Cigarettenfab Gmbh | Rauchbarer artikel |
US4941483A (en) | 1989-09-18 | 1990-07-17 | R. J. Reynolds Tobacco Company | Aerosol delivery article |
US5144962A (en) | 1989-12-01 | 1992-09-08 | Philip Morris Incorporated | Flavor-delivery article |
US5224498A (en) | 1989-12-01 | 1993-07-06 | Philip Morris Incorporated | Electrically-powered heating element |
US5060671A (en) | 1989-12-01 | 1991-10-29 | Philip Morris Incorporated | Flavor generating article |
GB2239807A (en) | 1990-01-09 | 1991-07-17 | Boc Group Plc | Anaesthetic vaporiser |
US5099861A (en) | 1990-02-27 | 1992-03-31 | R. J. Reynolds Tobacco Company | Aerosol delivery article |
US5366770A (en) | 1990-04-17 | 1994-11-22 | Xingwu Wang | Aerosol-plasma deposition of films for electronic cells |
ES2073685T5 (es) | 1990-08-02 | 2002-03-01 | Datex Ohmeda Inc | Vaporizador de anestesico. |
ATE179605T1 (de) | 1991-02-09 | 1999-05-15 | B S D Bio Science Dev Snc Di O | Antireaktive antiasthmatische wirkung von acetylsalicylsäure durch inhalation |
US5993805A (en) | 1991-04-10 | 1999-11-30 | Quadrant Healthcare (Uk) Limited | Spray-dried microparticles and their use as therapeutic vehicles |
US5639441A (en) | 1992-03-06 | 1997-06-17 | Board Of Regents Of University Of Colorado | Methods for fine particle formation |
US5318033A (en) | 1992-04-17 | 1994-06-07 | Hewlett-Packard Company | Method and apparatus for increasing the frame rate and resolution of a phased array imaging system |
AU660824B2 (en) | 1992-06-12 | 1995-07-06 | Teijin Limited | Pharmaceutical preparation for intra-airway administration |
US5284133A (en) * | 1992-07-23 | 1994-02-08 | Armstrong Pharmaceuticals, Inc. | Inhalation device with a dose-timer, an actuator mechanism, and patient compliance monitoring means |
US5915378A (en) | 1993-01-29 | 1999-06-29 | Aradigm Corporation | Creating an aerosolized formulation of insulin |
US5507277A (en) | 1993-01-29 | 1996-04-16 | Aradigm Corporation | Lockout device for controlled release of drug from patient-activateddispenser |
US5364838A (en) | 1993-01-29 | 1994-11-15 | Miris Medical Corporation | Method of administration of insulin |
US5558085A (en) | 1993-01-29 | 1996-09-24 | Aradigm Corporation | Intrapulmonary delivery of peptide drugs |
US5888477A (en) | 1993-01-29 | 1999-03-30 | Aradigm Corporation | Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin |
US5694919A (en) | 1993-01-29 | 1997-12-09 | Aradigm Corporation | Lockout device for controlled release of drug from patient-activated dispenser |
US5934272A (en) | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
US5743250A (en) | 1993-01-29 | 1998-04-28 | Aradigm Corporation | Insulin delivery enhanced by coached breathing |
US6024090A (en) | 1993-01-29 | 2000-02-15 | Aradigm Corporation | Method of treating a diabetic patient by aerosolized administration of insulin lispro |
US5666977A (en) | 1993-06-10 | 1997-09-16 | Philip Morris Incorporated | Electrical smoking article using liquid tobacco flavor medium delivery system |
WO1995001137A1 (en) | 1993-06-29 | 1995-01-12 | Voges Innovation Pty. Ltd. | Dispenser |
US5388574A (en) | 1993-07-29 | 1995-02-14 | Ingebrethsen; Bradley J. | Aerosol delivery article |
DE4328243C1 (de) | 1993-08-19 | 1995-03-09 | Sven Mielordt | Rauch- oder Inhalationsvorrichtung |
US5456247A (en) | 1993-08-26 | 1995-10-10 | Iowa State University Research Foundation, Inc. | Method for delivering drugs soluble in a vaporization vehicle |
FI98270C (fi) | 1993-11-29 | 1997-05-26 | Instrumentarium Oy | Menetelmä ja sovitelma anesteetin höyrystämisen yhteydessä |
US6102036A (en) | 1994-04-12 | 2000-08-15 | Smoke-Stop | Breath activated inhaler |
US5522385A (en) | 1994-09-27 | 1996-06-04 | Aradigm Corporation | Dynamic particle size control for aerosolized drug delivery |
US5758637A (en) | 1995-08-31 | 1998-06-02 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US5612053A (en) | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
US5874481A (en) | 1995-06-07 | 1999-02-23 | Alliance Pharmaceutical Corp. | Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents |
US5649554A (en) | 1995-10-16 | 1997-07-22 | Philip Morris Incorporated | Electrical lighter with a rotatable tobacco supply |
US5564442A (en) | 1995-11-22 | 1996-10-15 | Angus Collingwood MacDonald | Battery powered nicotine vaporizer |
US6041777A (en) | 1995-12-01 | 2000-03-28 | Alliance Pharmaceutical Corp. | Methods and apparatus for closed-circuit ventilation therapy |
SE9504580L (sv) | 1995-12-21 | 1997-06-22 | Siemens Elema Ab | Förfarande vid förgasning av en narkosvätska och en förgasare |
AUPN814496A0 (en) | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
US5699789A (en) | 1996-03-11 | 1997-12-23 | Hendricks; Mark R. | Dry powder inhaler |
IL126063A (en) | 1996-03-25 | 2002-04-21 | Lilly Co Eli | Medicinal products containing ulanzapine for the treatment of migraine pain |
JP2000507544A (ja) | 1996-03-25 | 2000-06-20 | イーライ・リリー・アンド・カンパニー | 痛みの治療方法 |
BR9708246A (pt) | 1996-03-25 | 1999-07-27 | Lilly Co Eli | Metodo para tratamento de dor |
UA48219C2 (uk) | 1996-03-25 | 2002-08-15 | Елі Ліллі Енд Компані | Композиція для вгамування болю (варіанти) та спосіб вгамування болю |
US5875776A (en) | 1996-04-09 | 1999-03-02 | Vivorx Pharmaceuticals, Inc. | Dry powder inhaler |
US5743251A (en) | 1996-05-15 | 1998-04-28 | Philip Morris Incorporated | Aerosol and a method and apparatus for generating an aerosol |
US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
GB9613015D0 (en) | 1996-06-21 | 1996-08-28 | Reckitt & Colman Inc | Device |
US5891885A (en) | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
US6290986B1 (en) | 1996-10-24 | 2001-09-18 | Pharmaceutical Applications Associates, Llc | Method and composition for transdermal administration of pharmacologic agents |
US6479074B2 (en) | 1996-10-24 | 2002-11-12 | Pharmaceutical Applications Associates Llc | Methods and transdermal compositions for pain relief |
US6131570A (en) | 1998-06-30 | 2000-10-17 | Aradigm Corporation | Temperature controlling device for aerosol drug delivery |
US6694975B2 (en) | 1996-11-21 | 2004-02-24 | Aradigm Corporation | Temperature controlling device for aerosol drug delivery |
DK1014943T3 (da) | 1997-02-05 | 2002-10-14 | Jago Res Ag | Medicinske aerosolformuleringer |
ZA982368B (en) | 1997-03-27 | 1998-09-23 | Akzo Nobel Nv | New therapeutic combinations |
DE19727297C2 (de) | 1997-06-27 | 2003-11-13 | Bosch Gmbh Robert | Verfahren zum Betreiben einer Brennkraftmaschine insbesondere eines Kraftfahrzeugs |
KR100289448B1 (ko) | 1997-07-23 | 2001-05-02 | 미즈노 마사루 | 향미발생장치 |
US6090212A (en) | 1997-08-15 | 2000-07-18 | Micro C Technologies, Inc. | Substrate platform for a semiconductor substrate during rapid high temperature processing and method of supporting a substrate |
US6403597B1 (en) | 1997-10-28 | 2002-06-11 | Vivus, Inc. | Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
US5900249A (en) | 1998-02-09 | 1999-05-04 | Smith; David J. | Multicomponent pain relief topical medication |
US6158431A (en) | 1998-02-13 | 2000-12-12 | Tsi Incorporated | Portable systems and methods for delivery of therapeutic material to the pulmonary system |
EP1080720A4 (en) | 1998-03-05 | 2002-06-05 | Nippon Shinyaku Co Ltd | FAT EMULSIONS FOR INHALATIVE ADMINISTRATION |
US20020086852A1 (en) | 1998-05-14 | 2002-07-04 | Cantor Jerome O. | Method for treating respiratory disorders associated with pulmonary elastic fiber injury |
US6211171B1 (en) | 1998-05-19 | 2001-04-03 | Dalhousie University | Use of antidepressants for local analgesia |
US6095153A (en) | 1998-06-19 | 2000-08-01 | Kessler; Stephen B. | Vaporization of volatile materials |
US6241969B1 (en) | 1998-06-26 | 2001-06-05 | Elan Corporation Plc | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
US6234167B1 (en) | 1998-10-14 | 2001-05-22 | Chrysalis Technologies, Incorporated | Aerosol generator and methods of making and using an aerosol generator |
US6255334B1 (en) | 1998-10-30 | 2001-07-03 | Pfizer Inc | 5HT 1 receptor agonists and metoclopramide for the treatment of migraine |
US6376550B1 (en) | 1999-02-09 | 2002-04-23 | Asta Medica Ag | Pharmaceutical compositions containing tramadol for migraine |
US6591839B2 (en) | 1999-02-17 | 2003-07-15 | Dieter Meyer | Filter material for reducing harmful substances in tobacco smoke |
EA200200424A1 (ru) | 1999-09-30 | 2002-12-26 | Ньюроджен Корпорейшн | Некоторые гетероциклы, замещенные алкилендиамином |
AU2001234005B2 (en) | 2000-02-28 | 2006-01-19 | Pharmakodex Limited | Improvements in or relating to the delivery of oral drugs |
US6632047B2 (en) | 2000-04-14 | 2003-10-14 | Board Of Regents, The University Of Texas System | Heater element for use in an in situ thermal desorption soil remediation system |
MY136453A (en) | 2000-04-27 | 2008-10-31 | Philip Morris Usa Inc | "improved method and apparatus for generating an aerosol" |
US6613308B2 (en) | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
US6514482B1 (en) | 2000-09-19 | 2003-02-04 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
US20020117175A1 (en) | 2000-10-27 | 2002-08-29 | Kottayil S. George | Thermal vaporizing device for drug delivery |
AUPR283801A0 (en) * | 2001-02-01 | 2001-03-01 | Australian National University, The | Chemical compounds and methods |
EP1383376A4 (en) | 2001-03-19 | 2006-03-08 | Praecis Pharm Inc | PHARMACEUTICAL FORMULATIONS WITH PROLONGED RELEASE |
US20030004142A1 (en) | 2001-04-18 | 2003-01-02 | Prior Christopher P. | Use of NSAIDs for prevention and treatment of cellular abnormalities of the lung or bronchial pathway |
US7585493B2 (en) | 2001-05-24 | 2009-09-08 | Alexza Pharmaceuticals, Inc. | Thin-film drug delivery article and method of use |
US20030118512A1 (en) | 2001-10-30 | 2003-06-26 | Shen William W. | Volatilization of a drug from an inclusion complex |
US7645442B2 (en) | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
JP2005503425A (ja) | 2001-05-24 | 2005-02-03 | アレックザ モレキュラー デリヴァリー コーポレイション | 所定の吸入ルートによる薬剤エステルの送出 |
US7090830B2 (en) | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
US6759029B2 (en) | 2001-05-24 | 2004-07-06 | Alexza Molecular Delivery Corporation | Delivery of rizatriptan and zolmitriptan through an inhalation route |
US20030032638A1 (en) | 2001-05-24 | 2003-02-13 | Kim John J. | Delivery of benzodiazepines through an inhalation route |
US7498019B2 (en) | 2001-05-24 | 2009-03-03 | Alexza Pharmaceuticals, Inc. | Delivery of compounds for the treatment of headache through an inhalation route |
US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
EP1392258B1 (en) | 2001-05-24 | 2008-11-26 | Alexza Pharmaceuticals, Inc. | Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
US6805853B2 (en) | 2001-11-09 | 2004-10-19 | Alexza Molecular Delivery Corporation | Delivery of diazepam through an inhalation route |
ATE452642T1 (de) * | 2001-06-19 | 2010-01-15 | Norbert Mueller | Verwendung von cox-2 inhibitoren zur behandlung von affectiven störungen |
US6638981B2 (en) | 2001-08-17 | 2003-10-28 | Epicept Corporation | Topical compositions and methods for treating pain |
AU2002363947A1 (en) | 2001-11-21 | 2003-07-24 | Alexza Molecular Delivery Corporation | Delivery of caffeine through an inhalation route |
EP1455875A2 (en) | 2001-11-21 | 2004-09-15 | Alexza Molecular Delivery Corporation | Open-celled substrates for drug delivery |
WO2003051367A1 (en) | 2001-12-18 | 2003-06-26 | Alexza Molecular Delivery Corporation | Parental analgesic formulations comprising fentanyl and a cannabinoid receptor agonist |
US6701922B2 (en) | 2001-12-20 | 2004-03-09 | Chrysalis Technologies Incorporated | Mouthpiece entrainment airflow control for aerosol generators |
US6772756B2 (en) | 2002-02-09 | 2004-08-10 | Advanced Inhalation Revolutions Inc. | Method and system for vaporization of a substance |
WO2003094900A1 (en) * | 2002-05-13 | 2003-11-20 | Alexza Molecular Delivery Corporation | Delivery of drug amines through an inhalation route |
US7263214B2 (en) | 2002-05-15 | 2007-08-28 | Ge Medical Systems Global Technology Company Llc | Computer aided diagnosis from multiple energy images |
US20060193788A1 (en) | 2002-11-26 | 2006-08-31 | Hale Ron L | Acute treatment of headache with phenothiazine antipsychotics |
WO2004022128A2 (en) * | 2002-09-06 | 2004-03-18 | Chrysalis Technologies Incorporated | Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
US6715416B1 (en) * | 2002-11-06 | 2004-04-06 | Mgs Mfg. Group, Inc. | Pod loader for transfer pad printing system |
US20040105818A1 (en) | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
US7550133B2 (en) | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
JP2006514633A (ja) | 2002-11-26 | 2006-05-11 | アレックザ ファーマシューティカルズ, インコーポレイテッド | 吸入によって送達される抗精神病薬を用いた頭痛の治療 |
US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
WO2004104490A1 (en) | 2003-05-21 | 2004-12-02 | Alexza Pharmaceuticals, Inc. | Self-contained heating unit and drug-supply unit employing same |
US20050034723A1 (en) | 2003-08-04 | 2005-02-17 | Bryson Bennett | Substrates for drug delivery device and methods of preparing and use |
WO2005014090A1 (en) | 2003-08-04 | 2005-02-17 | Alexza Pharmaceuticals, Inc. | Methods of determining film thicknesses for an aerosol delivery article |
EP1703932A1 (en) | 2003-12-15 | 2006-09-27 | Alexza Molecular Delivery Corporation | Treatment of breakthrough pain by drug aerosol inhalation |
US20050131739A1 (en) | 2003-12-16 | 2005-06-16 | Alexza Molecular Delivery Corporation | Methods for monitoring severity of panic attacks and other rapidly evolving medical events in real time |
US7402777B2 (en) | 2004-05-20 | 2008-07-22 | Alexza Pharmaceuticals, Inc. | Stable initiator compositions and igniters |
US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
US20060032496A1 (en) | 2004-08-12 | 2006-02-16 | Alexza Molecular Delivery Corporation | Inhalation actuated percussive ignition system |
US7581540B2 (en) | 2004-08-12 | 2009-09-01 | Alexza Pharmaceuticals, Inc. | Aerosol drug delivery device incorporating percussively activated heat packages |
EP1809240A4 (en) | 2004-10-12 | 2010-06-16 | Alexza Pharmaceuticals Inc | ADMINISTRATION OF A DRUG-FREE DRUG WITHOUT DANGER TO THE CARDIOVASCULAR SYSTEM |
-
2003
- 2003-11-20 AU AU2003294470A patent/AU2003294470B2/en not_active Ceased
- 2003-11-20 NZ NZ540207A patent/NZ540207A/en unknown
- 2003-11-20 WO PCT/US2003/037415 patent/WO2004047844A1/en active Application Filing
- 2003-11-20 MX MXPA05005611A patent/MXPA05005611A/es active IP Right Grant
- 2003-11-20 ES ES03789955T patent/ES2321292T3/es not_active Expired - Lifetime
- 2003-11-20 EP EP03789955A patent/EP1567164B1/en not_active Expired - Lifetime
- 2003-11-20 CA CA002507159A patent/CA2507159A1/en not_active Abandoned
- 2003-11-20 JP JP2004555617A patent/JP2006514934A/ja not_active Ceased
- 2003-11-20 CN CNA2003801041511A patent/CN1717237A/zh active Pending
- 2003-11-20 AT AT03789955T patent/ATE420647T1/de active
- 2003-11-20 CN CN2008101336457A patent/CN101371843B/zh not_active Expired - Lifetime
- 2003-11-20 US US10/719,540 patent/US8288372B2/en active Active
- 2003-11-20 DE DE60325888T patent/DE60325888D1/de not_active Expired - Lifetime
- 2003-11-20 DK DK03789955T patent/DK1567164T3/da active
- 2003-11-20 PT PT03789955T patent/PT1567164E/pt unknown
-
2009
- 2009-05-15 HK HK09104445.4A patent/HK1125845A1/xx not_active IP Right Cessation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3546226A (en) * | 1963-03-01 | 1970-12-08 | A Wander Sa Dr | 11-basic-substituted dibenzoxazepines |
JP2001518097A (ja) * | 1997-03-24 | 2001-10-09 | アドロール コーポレーション | 片頭痛の治療方法 |
JP2002515503A (ja) * | 1998-05-18 | 2002-05-28 | ノボ ノルディスク アクティーゼルスカブ | オピオイド受容体のサブタイプへの高い親和性を有する新規1,3,8−トリアザスピロ〔4,5〕デカノン |
WO2002000482A1 (en) * | 2000-06-23 | 2002-01-03 | R Rapich Limited | Trailer brake |
WO2002060870A2 (en) * | 2000-11-17 | 2002-08-08 | Adolor Corporation | Delta agonist analgesics |
WO2002098496A1 (en) * | 2001-06-05 | 2002-12-12 | Alexza Molecular Delivery Corporation | An aerosol forming device for use in inhalation therapy |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015520154A (ja) * | 2012-05-18 | 2015-07-16 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | (1r,4r)−6’−フルオロ−N,N−ジメチル−4−フェニル−4’,9’−ジヒドロ−3’H−スピロ[シクロヘキサン−1,1’−ピラノ[3,4,b]インドール]−4−アミンおよび抗うつ薬を含む医薬組成物 |
US9629825B2 (en) | 2012-05-18 | 2017-04-25 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid |
US10328055B2 (en) | 2012-05-18 | 2019-06-25 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indo]-4-amine and antidepressants |
Also Published As
Publication number | Publication date |
---|---|
WO2004047844A1 (en) | 2004-06-10 |
EP1567164B1 (en) | 2009-01-14 |
NZ540207A (en) | 2008-06-30 |
DE60325888D1 (de) | 2009-03-05 |
MXPA05005611A (es) | 2005-07-27 |
AU2003294470B2 (en) | 2009-09-17 |
HK1125845A1 (en) | 2009-08-21 |
AU2003294470A1 (en) | 2004-06-18 |
ATE420647T1 (de) | 2009-01-15 |
DK1567164T3 (da) | 2009-05-18 |
CN1717237A (zh) | 2006-01-04 |
US8288372B2 (en) | 2012-10-16 |
CN101371843A (zh) | 2009-02-25 |
ES2321292T3 (es) | 2009-06-04 |
CA2507159A1 (en) | 2004-06-10 |
CN101371843B (zh) | 2012-09-26 |
EP1567164A1 (en) | 2005-08-31 |
WO2004047844A8 (en) | 2007-01-25 |
US20040102434A1 (en) | 2004-05-27 |
PT1567164E (pt) | 2009-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2006514934A (ja) | 疼痛治療用薬剤製造のためのロキサピンまたはアモキサピンの使用 | |
Miyamoto | Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders | |
JP4634008B2 (ja) | 2h−ベンズイミダゾール−2−オン、1,3−ジヒドロ−1−(2−{4−[3−(トリフルオロメチル)フェニル]−1−ピペラジニル}エチル)−及びその生理学的に許容される酸付加塩の新規使用 | |
US20110111014A1 (en) | Methods and compositions for treatment of neurological disorders | |
US20070093546A1 (en) | Use of rotigotine for the treatment of depression | |
JP2006514633A (ja) | 吸入によって送達される抗精神病薬を用いた頭痛の治療 | |
US20090203731A1 (en) | Treatment of depression and other affective disorders | |
KR20090034810A (ko) | 멜라토닌 효능제 치료 | |
US20060246131A1 (en) | Use of metformin to counteract weight gain associated with psychotropic medications | |
EP2624821B1 (en) | Combination therapy for the treatment of depression and other non-infectious diseases | |
JP2007508236A (ja) | うつ病およびその他の情動障害を治療する方法 | |
JP2017534613A (ja) | デクスメデトミジン製剤を使用する睡眠障害の予防または治療 | |
WO2022246572A1 (en) | Hallucinogen-fatty acid combination | |
JP2005512965A (ja) | 不穏四肢症候群および定期的四肢運動障害の処置に有用な抗痙攣誘導体 | |
US9181201B2 (en) | Method of treatment of anxiety disorder comorbid with depression disorder | |
US20100016377A1 (en) | Use of a p38 Kinase Inhibitor for Treating Psychiatric Disorders | |
BR112019011334A2 (pt) | uso de 5-[[4-[2-[5-(1-hidroxietil)piridin-2-il]etoxi]fenil]metil]-1,3-tiazolidina-2,4-diona e seus sais | |
JP2021505629A (ja) | 認知症および神経変性状態における興奮、精神病および認知機能低下のためのシクロベンザプリン処置 | |
AU2021359134A1 (en) | Compositions and uses thereof | |
Kang et al. | The effect of DA-8159 on corpus cavernosal smooth muscle relaxation and penile erection in diabetic rabbits | |
JP2020075938A (ja) | 神経精神系障害の治療のための組成物および方法 | |
EP3130339B1 (en) | A compound for use in the treatment of comorbid anxiety disorder and depression disorder | |
Danyeli et al. | Ketamine in Psychiatric Disorders | |
US10426836B2 (en) | Compositions and methods for treating stress-related disorders | |
WO2023186826A1 (en) | 5-meo-dmt for use in the treatment of postpartum depression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20061120 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20090716 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20090724 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20090724 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100430 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100802 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110118 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110418 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110425 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110719 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120118 |
|
A045 | Written measure of dismissal of application [lapsed due to lack of payment] |
Free format text: JAPANESE INTERMEDIATE CODE: A045 Effective date: 20120525 |